| CPS
™ Pelletisation Technology
The CPS ™ Pelletisation Technology is a direct fluid bed pelletisation
technology, originally invented by Glatt GmbH in Binzen, Germany,
in 2000.
Its special features are characterized
by a modified fluid bed rotor system with a conical shaped rotating
disc plus additional devices for directed movement of particles.
To start processing, no inert starting beads are required. Spraying
of various liquids (organic and inorganic) as well as addition of
dry powder are also possible. By means of rolling particles movement,
CPS™ Pelletisation Technology clearly defines the densification
of particles.
Typical features of CPS-pellet products are:
o Spherical and smooth pellet surfaces
o High density, low porosity
o Low attrition and friability
o Dust free surfaces
o Narrow particle size distributions, e.g. +/- 50 µm
o Yield typically > 90 %
o Wide range of mean particle sizes feasible, e.g. ~ 100 to 1400
µm
Realisation of matrix controlled modified release
pellet preparations

SEM picture of a CPS extended release matrix
pellet
Pro Cell™ Technology
The Pro Cell™ Technology is a fluidised bed agglomeration
technology for the manufacture of very high concentrated almost
spherical particles.
The ProCell fluid bed granulation process is originally performed
as melt granulation process, but is now also prosecuted as aqueous
or solvent based agglomeration procedure. Due to the design of the
process chamber and its unique processing characteristics, drug
substance loadings up to 100 % are feasible. The particle size range
is adjustable over a broad size range. The agglomeration process
is in particular suitable for products with inherent stickiness.

Equipment and process scheme

SEM picture of a cross-section of a ProCell
active ingredient pellet, drug loading 100 % |